In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot. Reading time 3 minutes Next-generation vaccines could make the flu season ...

Pfizer and BioNTech, makers of the Food and Drug Administration-approved COVID-19 vaccine Comirnaty, shared today that their vaccine is effective among children ages 5 to 11 and that they will seek ...

Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, though fewer-than-expected cases in a study made it hard to determine how well it works on a ...

New research suggests that Pfizer’s COVID-19 vaccine can protect against a mutation found in two highly contagious variants of the coronavirus that erupted in Britain and South Africa. Those variants ...

Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.

Everything you need to know about the COVID vaccine, when you'll get it, how much it will cost and what it means.

Pfizer and French vaccine company Valneva last week released phase 3 clinical trial data for PF-0730740, a four-dose Lyme disease vaccine they developed together that is about 70% effective. Lyme ...

Pfizer says its COVID-19 vaccine works for children ages 5 to 11. The vaccine maker said Monday it plans to seek authorization for this age group soon in the U.S., Britain and Europe. The vaccine made ...

The COVAX programme has signed deals for hundreds of millions of doses to vaccinate people in poor and lower-middle income ...